Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nion-Larmurier

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Gastroenterologie Clinique Et Biologique|March 24, 2009
[Celiac disease]I Nion-Larmurier, J Cosnes
Pathologie-Biologie|May 31, 2011
[Complications of celiac disease]J Cosnes, I Nion-Larmurier
Histopathology|February 22, 2005
Neutropenic enterocolitis in acute myeloblastic leukaemiaN Mourra, I Nion-Larmurier, R Parc, et al.
Gut|January 14, 2005
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgeryJ Cosnes, I Nion-Larmurier, L Beaugerie, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2009
Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprineP Seksik, J Cosnes, H Sokol, et al.
Journal of Crohn'S & Colitis|January 21, 2014
Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel diseaseS Rajca, P Seksik, A Bourrier, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 27, 2015
Management of acute sigmoid volvulus: short- and long-term resultsM Bruzzi, J H Lefèvre, B Desaint, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2016
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's diseaseJ Cosnes, H Sokol, A Bourrier, et al.
Inflammatory Bowel Diseases|February 25, 2009
Low counts of Faecalibacterium prausnitzii in colitis microbiotaH Sokol, P Seksik, J P Furet, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Gastroenterologie Clinique Et Biologique|March 24, 2009
[Celiac disease]I Nion-Larmurier, J Cosnes
Pathologie-Biologie|May 31, 2011
[Complications of celiac disease]J Cosnes, I Nion-Larmurier
Histopathology|February 22, 2005
Neutropenic enterocolitis in acute myeloblastic leukaemiaN Mourra, I Nion-Larmurier, R Parc, et al.
Gut|January 14, 2005
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgeryJ Cosnes, I Nion-Larmurier, L Beaugerie, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2009
Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprineP Seksik, J Cosnes, H Sokol, et al.
Journal of Crohn'S & Colitis|January 21, 2014
Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel diseaseS Rajca, P Seksik, A Bourrier, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 27, 2015
Management of acute sigmoid volvulus: short- and long-term resultsM Bruzzi, J H Lefèvre, B Desaint, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2016
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's diseaseJ Cosnes, H Sokol, A Bourrier, et al.
Inflammatory Bowel Diseases|February 25, 2009
Low counts of Faecalibacterium prausnitzii in colitis microbiotaH Sokol, P Seksik, J P Furet, et al.
Pageof 1